Opportunity Information: Apply for PAR 22 241

The funding opportunity PAR 22-241, titled "NIAID Research Opportunities for New and 'At-Risk' Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)," is a National Institutes of Health (NIH) discretionary grant program that invites applications for R01 awards supporting independent research projects aligned with the scientific missions of the participating NIH Institutes and Centers, including NIAID. The central purpose is to strengthen and diversify the biomedical research workforce by providing research support to investigators who are early in their independent careers ("New Investigators") as well as investigators considered "At-Risk," meaning individuals who may be in jeopardy of losing research independence or continuity and could particularly benefit from sustained R01-level support. Clinical trials are permitted but not required, which allows applicants to propose either mechanistic/basic studies, translational work, population-level research, or clinical research depending on what best fits their aims and the participating Institute or Center missions.

A major emphasis of this FOA is broadening participation in health-related research by encouraging applications from investigators from diverse backgrounds, especially those from groups underrepresented in the health-related sciences. The announcement explicitly references the NIH-wide diversity interest notice (NOT-OD-20-031) as a guiding context for the kinds of underrepresentation NIH aims to address. In practical terms, the program is structured to encourage eligible investigators, working with their institutions, to submit R01 applications that help them establish or maintain a productive, independent research trajectory. The FOA also notes that investigators in certain priority categories (referred to as categories A and B within the program framework) are particularly encouraged to apply, signaling NIH interest in focusing support on specific diversity and career-stage circumstances described in the full FOA.

The eligible applicant pool is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations with or without 501(c)(3) status (excluding higher education institutions when specified); for-profit organizations other than small businesses; small businesses; and other eligible entities. The FOA also highlights eligible institution types often associated with serving historically underrepresented communities and building research capacity, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). Faith-based or community-based organizations, eligible federal agencies, regional organizations, and tribal governments or tribal organizations (including those other than federally recognized tribes) are also included among those that may apply, as appropriate.

On the international eligibility side, the FOA draws an important distinction. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply as the primary applicant organization. However, non-domestic components of U.S. organizations are eligible, and foreign components are allowed under NIH policy as defined in the NIH Grants Policy Statement. This means a U.S.-based applicant institution can include foreign collaborators, foreign performance sites, or other foreign components when scientifically justified and consistent with NIH rules, but the applicant organization itself must be domestic.

Administrative details in the source information show that the opportunity is an NIH grant under the health funding activity category, associated with CFDA number 93.855. The FOA was created on September 21, 2022, and the original closing date listed is September 19, 2023. The provided excerpt does not specify an award ceiling or expected number of awards, which typically means applicants should consult the full FOA and NIH standard R01 budget guidance (including any Institute-specific constraints) to understand budget expectations, project period limits, and any special review or award considerations tied to new/at-risk investigator status and workforce diversity goals.

Overall, this FOA can be read as an R01 pathway designed not only to fund high-quality, mission-relevant science, but also to reduce structural barriers to sustained research independence for investigators from underrepresented backgrounds and for investigators at vulnerable career transition points. The program encourages these investigators to partner closely with their institutions to submit competitive, independent research applications that can support long-term career stability and broaden representation in NIH-funded research.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIAID Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855.
  • This funding opportunity was created on 2022-09-21.
  • Applicants must submit their applications by 2023-09-19. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 22 241

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)

Previous opportunity: Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 22 241

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 22 241) also looked into and applied for these:

Funding Opportunity
Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (UT1, UT2 Clinical Trail Not Allowed) Apply for RFA TR 22 031

Funding Number: RFA TR 22 031
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) (U01 Clinical Trial Not Allowed) Apply for RFA NS 22 029

Funding Number: RFA NS 22 029
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,750,000
REQUEST FOR INFORMATION (RFI); Lowland Health Apply for 72066322RFI000011

Funding Number: 72066322RFI000011
Agency: Ethiopia USAID-Addis Ababa
Category: Health
Funding Amount: Case Dependent
Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed) Apply for RFA AI 22 059

Funding Number: RFA AI 22 059
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional) Apply for RFA HG 22 027

Funding Number: RFA HG 22 027
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Diversity Centers for Genome Research (U54 Clinical Trials Optional) Apply for RFA HG 22 026

Funding Number: RFA HG 22 026
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,400,000
AHRQ Mentored Research Scientist Career Development Award (K01) Apply for PA 22 255

Funding Number: PA 22 255
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Therapeutics for Eliminating Hepatitis B Virus cccDNA (R21/R33 Clinical Trial Not Allowed) Apply for RFA AI 22 068

Funding Number: RFA AI 22 068
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Genetic Tools for Understanding Rickettsial and Related Infections (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 22 047

Funding Number: RFA AI 22 047
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Required) Apply for RFA AG 23 034

Funding Number: RFA AG 23 034
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Immunity in Older Adults (U01 Clinical Trial Not Allowed) Apply for RFA AI 22 060

Funding Number: RFA AI 22 060
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Community Partnerships to Advance Science for Society (ComPASS): Coordination Center (U24 Clinical Trial Optional) Apply for RFA RM 23 001

Funding Number: RFA RM 23 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
USAID/Ethiopia Health Activities Industry days Apply for 72066322SN00012

Funding Number: 72066322SN00012
Agency: Ethiopia USAID-Addis Ababa
Category: Health
Funding Amount: Case Dependent
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06) Apply for PAR 22 253

Funding Number: PAR 22 253
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) Apply for RFA HL 24 005

Funding Number: RFA HL 24 005
Agency: National Institutes of Health
Category: Health
Funding Amount: $75,000
Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional) Apply for RFA AT 23 006

Funding Number: RFA AT 23 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
USAID/Bangladesh Request for Information on USAID’s Accelerating Reductions in Adolescent Childbearing Apply for 72038823RFI00003

Funding Number: 72038823RFI00003
Agency: Bangladesh USAID-Dhaka
Category: Health
Funding Amount: Case Dependent
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24 Clinical Trials Not Allowed) Apply for PAR 23 039

Funding Number: PAR 23 039
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) Apply for PAR 22 248

Funding Number: PAR 22 248
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) Apply for PAR 22 252

Funding Number: PAR 22 252
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 22 241", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: